Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation

Liver Transplantation

Volumn 21, Issue 3, 2015, Pages 369-380

  Lexmond, Willem S ^a   Van Dael, Carin M L ^a   Scheenstra, René ^a   Goorhuis, Joanne F ^a   Sieders, Egbert ^b   Verkade, Henkjan J ^a   Van Rheenen, Patrick F ^a   Kömhoff, Martin ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILIRUBIN; CREATININE; ALB PROTEIN, HUMAN; PROTEIN BINDING; SERUM ALBUMIN;

ACUTE LIVER FAILURE; ADOLESCENT; ALBUMIN DIALYSIS; AMMONIA BLOOD LEVEL; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN HERNIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT SURVIVAL; HEPATIC ENCEPHALOPATHY; HIGH URGENCY LIVER TRANSPLANTATION; HUMAN; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; NEWBORN; ORGAN DONOR; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SEPSIS; SEVERE HEPATIC IMPAIRMENT; TREATMENT OUTCOME; ADVERSE EFFECTS; AGE; BLOOD; CASE CONTROL STUDY; COMPLICATION; DETOXIFICATION; DISEASE COURSE; END STAGE LIVER DISEASE; HOSPITAL ADMISSION; METABOLISM; MORTALITY; PRESCHOOL CHILD; PROCEDURES; SEVERITY OF ILLNESS INDEX; TIME;

ADOLESCENT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; END STAGE LIVER DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INFANT; INFANT, NEWBORN; LIVER TRANSPLANTATION; MALE; PROTEIN BINDING; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SORPTION DETOXIFICATION; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84923540819     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24037     Document Type: Article

References (44)

1. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010;376:190-201.
2. Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care 2007;23:129-135.
3. McDiarmid SV, Merion RM, Dykstra DM, Harper AM. Selection of pediatric candidates under the PELD system. Liver Transpl 2004;10(suppl 2):S23-S30.
4. Gaspari R, Cavaliere F, Sollazzi L, Perilli V, Melchionda I, Agnes S, et al. Molecular Adsorbent Recirculating System (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. Transplant Proc 2009;41:253-258.
5. Wiesner RH. MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease. Liver Transpl 2004;10(suppl 2):S17-S22.
6. Bernal W, Cross TJ, Auzinger G, Sizer E, Heneghan MA, Bowles M, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol 2009;50:306-313.
7. Nadalin S, Heuer M, Wallot M, Auth M, Schaffer R, Sotiropoulos GC, et al. Paediatric acute liver failure and transplantation: the University of Essen experience. Transpl Int 2007;20:519-527.
8. Tissieres P, Sasbón JS, Devictor D. Liver support for fulminant hepatic failure: is it time to use the Molecular Adsorbents Recirculation system in children? Pediatr Crit Care Med 2005;6:585-591.
9. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, et al. Prometheus-a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-990.
10. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, et al. Effect of the Molecular Adsorbent Recirculating System and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10:R108.
11. Chawla LS, Georgescu F, Abell B, Seneff MG, Kimmel PL. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 2005;45:e51-e56.
12. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993;39:M621-M625.
13. Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17:809-813.
14. Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 1996;19:677-691.
15. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular Adsorbent Recycling System (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-330.
16. Lee JY, Kim SB, Chang JW, Park SK, Kwon SW, Song KW, et al. Comparison of the Molecular Adsorbent Recirculating System and plasmapheresis for patients with graft dysfunction after liver transplantation. Transplant Proc 2010;42:2625-2630.
17. Mitzner SR, Stange J, Klammt S, Koball S, Hickstein H, Reisinger EC. Albumin dialysis MARS: knowledge from 10 years of clinical investigation. ASAIO J 2009;55:498-502.
18. Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-1862.
19. Vaid A, Chweich H, Balk EM, Jaber BL. Molecular Adsorbent Recirculating System as artificial support therapy for liver failure: a meta-analysis. ASAIO J 2012; 58:51-59.
20. Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013;159:522-531.
21. Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al.; for RELIEF study group. Extracorporeal albumin dialysis with the Molecular Adsorbent Recirculating System in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013;57:1153-1162.
22. Schaefer B, Schmitt CP. The role of Molecular Adsorbent Recirculating System dialysis for extracorporeal liver support in children. Pediatr Nephrol 2013;28:1763-1769.
23. Jain V, Dhawan A. Quest for life on MARS: mission incomplete. J Pediatr Gastroenterol Nutr 2014;58:140-141.
24. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-658.
25. Ozanne B, Nelson J, Cousineau J, Lambert M, Phan V, Mitchell G, et al. Threshold for toxicity from hyperammonemia in critically ill children. J Hepatol 2012;56:123-128.
26. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
27. Liu E, MacKenzie T, Dobyns EL, Parikh CR, Karrer FM, Narkewicz MR, Sokol RJ. Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol 2006;44:134-141.
28. McDiarmid SV, Anand R, Lindblad AS; for Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a Pediatric End-Stage Liver Disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74:173-181.
29. Sanchez MC, D'Agostino DE. Pediatric End-Stage Liver Disease score in acute liver failure to assess poor prognosis. J Pediatr Gastroenterol Nutr 2011;54:193-196.
30. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Volovat C, Dimitriu AG, Cristogel F, Bizo A. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003;23(suppl 3):21-27.
31. Da Costa M, Lee MK, Lee HL, Aw M, Lee KH, Phua KB, et al. MARS liver dialysis in children with acute liver failure. Ann Acad Med Singapore 2004;33(suppl):S73-S74.
32. Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, et al. Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 2005;40:54-59.
33. Wai CT, Lim SG, Aung MO, Lee YM, Sutedja DS, Dan YY, et al. MARS: a futile tool in centres without active liver transplant support. Liver Int 2007;27:69-75.
34. Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, et al. Pediatric acute liver failure with Molecular Adsorbent Recirculating System treatment. Transplant Proc 2008;40:1921-1924.
35. Rusu EE, Voiculescu M, Zilisteanu DS, Ismail G. Molecular Adsorbents Recirculating System in patients with severe liver failure. Experience of a single Romanian centre. J Gastrointestin Liver Dis 2009;18:311-316.
36. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant 2011;26:3633-3639.
37. Rustom N, Bost M, Cour-Andlauer F, Lachaux A, Brunet AS, Boillot O, et al. Effect of Molecular Adsorbents Recirculating System treatment in children with acute liver failure caused by Wilson disease. J Pediatr Gastroenterol Nutr 2014;58:160-164.
38. Sturm E, Franssen CF, Gouw A, Staels B, Boverhof R, De Knegt RJ, et al. Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver 2002;22(suppl 2):72-75.
39. Voiculescu M, Ioanitescu S, Rusu E, Micu D, Mihaila M, Micu L. Successful application of MARS therapy in a 7 year-old patient with hepatic chronic rejection and severe cholestatic syndrome. Rom J Gastroenterol 2002; 11:135-140.
40. Hommann M, Kasakow LB, Geoghegan J, Kornberg A, Schotte U, Fuchs D, et al. Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. Pediatr Transplant 2002;6:340-343.
41. Prokurat S, Grenda R, Lipowski D, Kaliciński P, Migdal M. MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium-copper acute intoxication: a paediatric case report. Liver 2002;22(suppl 2): 76-77.
42. Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH; for Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. J Pediatr 2011;159:813-818.
43. Yamashiki N, Sugawara Y, Tamura S, Nakayama N, Oketani M, Umeshita K, et al. Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey. Liver Transpl 2012;18:1069-1077.
44. Pezzati D, Ghinolfi D, De Simone P, Tincani G, Fiorenza G, Filipponi F. Organ sharing in the management of acute liver failure. Transplant Proc 2013;45:1270-1272.